K2M Group Holdings, a global leader of complex spine and minimally invasive solutions focused on achieving three-dimensional Total Body Balance, today announced that it has acquired the exclusive license to a robust portfolio of 17 issued and pending patents for expandable 3D printed implants interbody technology. The license is another example of K2M’s focus on being a market-leading innovator and provider of expandable solutions for a diverse range of TLIF, Lateral, PLIF, and other procedures. The licensed IP is expected to provide K2M’s interbody portfolio with expansion capabilities that exceed many expandable devices currently on the market.
K2M also announced its intent to integrate its 3D printing technology, Lamellar 3D Titanium Technology™, into new products developed with this intellectual property. This will further strengthen the Company’s leadership in the 3D printing of spinal devices. K2M was the first leading spine company to market a 3D-printed spinal implant and offers the most comprehensive portfolio of 3D-printed spinal devices on the market today. The Company’s 3D-printed portfolio currently extends across three product families and provides differentiated solutions to help achieve spinal balance in complex, minimally invasive, and degenerative spine procedures.
“We are excited to have obtained the exclusive rights to this intellectual property portfolio and look forward to integrating our 3D printing technology with new expandable spinal devices as part of our effort to build a comprehensive portfolio of industry-leading, 3D-printed solutions to address the full range of spinal pathologies,” said K2M President and CEO, Eric Major. “This strategic investment to enhance our intellectual property portfolio—coupled with our recent announcements around MOJAVE PL 3D Expandable, SAHARA AL Expandable, and our Balance ACS platform—are key milestones to drive our strategy to be the technology and market leader in the next generation of 3D-printed expandables.”
K2M recently announced two additions to its expandable portfolio. K2M received 510(k) clearance from the U.S. Food & Drug Administration (FDA) for the MOJAVE PL 3D Expandable Interbody System, a first-to-market, 3D-printed, FDA-cleared expandable posterior-lumbar interbody system featuring K2M’s Lamellar 3D Titanium Technology. The Company also introduced the SAHARA AL Expandable Stabilization System, the only lordotic expandable interbody device with integrated screw fixation on the market to help achieve spinal balance.
Balance ACS (BACS) provides solutions focused on achieving balance of the spine by addressing each anatomical vertebral segment with a 360-degree approach to the axial, coronal, and sagittal planes, emphasizing Total Body Balance as an important component of surgical success.